-
Mashup Score: 2Uptake of Aspirin as Lynch Syndrome Chemoprevention Remains Low. What Oncologists Need to Know to Support Patients - 2 day(s) ago
Only about one-third of patients with Lynch syndrome are using aspirin or nonsteroidal anti-inflammatory agents as a form of chemoprevention, according to a new study published in JCO Precision Oncology.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9Adoptive Cell Therapy in Solid Tumors: How Can We Mitigate Risk and Optimize Rewards? - 3 day(s) ago
Although immune checkpoint inhibitor therapy has revolutionized the treatment of solid tumors, immunologically “cold” tumors remain difficult to treat. Adoptive cell therapy—particularly, tumor-infiltrating lymphocyte therapy—shows promise in this space.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Adoptive Cell Therapy in Solid Tumors: How Can We Mitigate Risk and Optimize Rewards? - 3 day(s) ago
Although immune checkpoint inhibitor therapy has revolutionized the treatment of solid tumors, immunologically “cold” tumors remain difficult to treat. Adoptive cell therapy—particularly, tumor-infiltrating lymphocyte therapy—shows promise in this space.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4
Nkeiruka Nwobu, Cheryssa Hislop, and Alejandra Curbelo-Paz, share their personal stories of how they balanced academics, community, and self-care during their first years of medical school.
Source: connection.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Thoracic Cancer - 5 day(s) ago
Thoracic Cancer
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 14
Combustible tobacco use has reached historic lows, demonstrating the importance of proven strategies to reduce smoking since publication of the 1964 Surgeon General’s report. In contrast, the use of electronic nicotine delivery systems (ENDS), specifically e-cigarettes, has grown to alarming rates and threatens to hinder progress against tobacco use. A major concern is ENDS use by youth and adults who never previously used tobacco. While ENDS emit fewer carcinogens than combustible tobacco, preliminary evidence links ENDS use to DNA damage and inflammation, key steps in cancer development. Furthermore, high levels of nicotine can also increase addiction, raise blood pressure, interfere with brain development, and suppress the immune system. The magnitude of long-term health risks will remain unknown until longitudinal studies are completed. ENDS have been billed as a promising tool for combustible tobacco cessation, but further evidence is needed to assess their potential efficacy for
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
We applaud @US_FDA's final rule raising min. age for certain restrictions on tobacco product sales. #ASCOAdvocacy has long supported FDA's role in regulating flavored tobacco & electronic nicotine devices to reduce # of new tobacco-related cancer cases. https://t.co/bh6qenngOX https://t.co/4ZHHkJ5cy7
-
-
Mashup Score: 24ASCO Election - 7 day(s) ago
ASCO Election
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
Three recent updates may alter the TKI selection paradigm in chronic myeloid leukemia chronic phase: asciminib has shown high response rates and few adverse events, generic imatinib has decreased in cost significantly, and dasatinib is now a generic drug. While imatinib and dasatinib are attractive and effective frontline options, asciminib’s high cost may render it more appropriate for patients who experience tolerability issues with other TKIs.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
What's the best frontline TKI for newly diagnosed CML-CP? Recent updates re: effectiveness and cost may alter the selection paradigm. @KellySchoenbeck, @MazieTsangMD & Dr. Neil P. Shah explore the options for #ASCODailyNews: https://t.co/LrkqRjXPzh #ChronicMyeloidLeukemia #leusm https://t.co/ICFpAmQnZB
-
-
Mashup Score: 11ASCO Election - 11 day(s) ago
ASCO Election
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5
For three medical students who participated in ASCO’s Oncology Summer Internship (OSI) Program, the meaning of health equity is personal, driving them to pursue careers in medicine.
Source: connection.asco.orgCategories: General Medicine News, Partners & KOLsTweet
Only about 1/3 of patients w/ #LynchSyndrome are using aspirin/NSAIDs as a form of chemoprevention, according to a recent study published in @JCOPO_ASCO. #ASCODailyNews covers the study & discusses what oncologists need to know to support patients: https://t.co/Y9ajkWt9UF https://t.co/mwz6cpUYpf